# A Study in Healthy Volunteers to Compare the Pharmacokinetics of Sotorasib Administered as 1 or 2 Tablets

> **NCT05327491** · PHASE1 · COMPLETED · sponsor: **Amgen** · enrollment: 146 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** Sotorasib

## Key facts

- **NCT ID:** NCT05327491
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-21
- **Primary completion:** 2022-07-17
- **Final completion:** 2022-07-17
- **Target enrollment:** 146 (ACTUAL)
- **Last updated:** 2023-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05327491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05327491, "A Study in Healthy Volunteers to Compare the Pharmacokinetics of Sotorasib Administered as 1 or 2 Tablets". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT05327491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*